Phase II clinical trial of liposomal-encapsulated doxorubicin citrate and docetaxel, associated with trastuzumab, as neoadjuvant treatment in stages II and IIIA HER2-overexpressing breast cancer patients. GEICAM 2003-03 study
Titel:
Phase II clinical trial of liposomal-encapsulated doxorubicin citrate and docetaxel, associated with trastuzumab, as neoadjuvant treatment in stages II and IIIA HER2-overexpressing breast cancer patients. GEICAM 2003-03 study
Auteur:
Antón, A. Ruiz, A. Plazaola, A. Calvo, L. Seguí, M.A. Santaballa, A. Muñoz, M. Sánchez, P. Miguel, A. Carrasco, E. Lao, J. Camps, J. Alfaro, J. Antolín, S. Cámara, M.C.